MedPath

Petrolatum

Generic Name
Petrolatum
Brand Names
A+d Diaper Rash, Anbesol Cold Sore Therapy, Calazime Skin Protectant, Calmoseptine Ointment, DermaCerin, Flanders, Lubrifresh P.M., Periguard, Preparation H Cream, Preparation H Reformulated Jun 2013, Refresh Lacri-lube, Refresh PM, Resinol, Soothe & Cool Skin Paste, Soothe Night Time, Stye, Systane, Systane Nighttime, Tears Again Ointment, Vusion, Zincofax
Drug Type
Small Molecule
CAS Number
8009-03-8
Unique Ingredient Identifier
B6E5W8RQJ4
Background

A colloidal system of semisolid hydrocarbons obtained from petroleum. It is used as an ointment base, topical protectant, and lubricant.

Indication

For use as an over the counter skin protectant . Commonly used to treat diaper rash and chapped lips .

Associated Conditions
Dermabrasion, Diaper Rash, Dry Skin, Itching of the perianal area, Pain, Skin Irritation, Burning skin sensation, Minor burns
Associated Therapies
Skin protectant

Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization

Not Applicable
Completed
Conditions
Seborrheic Keratosis
Acrochordon
Interventions
Drug: Sodium Fusidate 2 % Topical Ointment
First Posted Date
2022-04-29
Last Posted Date
2022-05-05
Lead Sponsor
Indonesia University
Target Recruit Count
22
Registration Number
NCT05353374
Locations
🇮🇩

Dermatology and Venereology Clinic, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia

Efficacy of Tazarotene in Treatment of Verruca Plana

First Posted Date
2022-04-06
Last Posted Date
2022-05-16
Lead Sponsor
Zagazig University
Target Recruit Count
80
Registration Number
NCT05314127
Locations
🇪🇬

Dermatology department, Zagazig University Hospitals, Faculty of Medicine, Zagazig University, Zagazig, Select Region, Egypt

Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.

Phase 2
Completed
Conditions
Covid19
Interventions
First Posted Date
2021-07-06
Last Posted Date
2021-07-06
Lead Sponsor
Turn Therapeutics
Target Recruit Count
85
Registration Number
NCT04951349
Locations
🇵🇦

Gorgas Memorial Research Hospital, Panama City, Panama

🇵🇦

Hospital Modular COVID-19, Panama City, Panama

🇵🇦

Hospital Santo Tomas, Panama City, Panama

Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial

First Posted Date
2019-08-28
Last Posted Date
2019-08-28
Lead Sponsor
Zagazig University
Target Recruit Count
50
Registration Number
NCT04071106

Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy Participants

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2019-04-16
Last Posted Date
2019-05-24
Lead Sponsor
Pfizer
Target Recruit Count
20
Registration Number
NCT03916250
Locations
🇯🇵

Medical Corporation Heishinkai OPHAC Hospital, Osaka-shi, Osaka, Japan

Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2

Phase 4
Conditions
Diabetes Mellitus, Type 2
Xerosis Cutis
Interventions
First Posted Date
2019-01-24
Last Posted Date
2019-01-24
Lead Sponsor
Indonesia University
Target Recruit Count
159
Registration Number
NCT03815305
Locations
🇮🇩

Universitas Indonesia, Jakarta Pusat, Jakarta, Indonesia

Zinc Oxide Versus Petrolatum Following Skin Surgery

Early Phase 1
Recruiting
Conditions
Surgical Site Infection
Surgical Incision
Surgical Wound
Scar
Hypertrophic Scar
Surgery--Complications
Interventions
First Posted Date
2018-06-19
Last Posted Date
2025-03-20
Lead Sponsor
Melissa Pugliano-Mauro
Target Recruit Count
30
Registration Number
NCT03561376
Locations
🇺🇸

UPMC Dermatology St. Margaret, Pittsburgh, PA, Pennsylvania, United States

Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU

Phase 2
Completed
Conditions
Staphylococcus
Interventions
First Posted Date
2016-11-18
Last Posted Date
2020-12-21
Lead Sponsor
Crouse Hospital
Target Recruit Count
216
Registration Number
NCT02967432
Locations
🇺🇸

Crouse Hospital - Neonatal Intensive Care Unit, Syracuse, New York, United States

Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery

Phase 4
Completed
Conditions
Hypertrophic Scars
Interventions
Drug: 0.05% Clobetasol propionate
First Posted Date
2015-07-01
Last Posted Date
2015-07-01
Lead Sponsor
Mahidol University
Target Recruit Count
24
Registration Number
NCT02487212
Locations
🇹🇭

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

First Posted Date
2015-02-04
Last Posted Date
2025-02-24
Lead Sponsor
LEO Pharma
Target Recruit Count
16
Registration Number
NCT02355639
Locations
🇩🇪

Charité - Universitaetsmedizin Berlin, Department of Dermatology and Allergy, Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath